Compositions and methods for polynucleotide sequencing

Patent metadata

Field	Value
Publication number	US-11879155-B2
Application number	US-202117329482-A
Country	US
Kind code	B2
Filing date	May 25, 2021
Priority date	Nov 26, 2013
Publication date	Jan 23, 2024
Grant date	Jan 23, 2024

Abstract

Methods and compositions for characterizing a target polynucleotide, including, characterizing the sequence of the target polynucleotide, using the fractional translocation steps of the target polynucleotide's translocation through a pore.

First claim

What is claimed is:

1. A method of sequencing a target polynucleotide, the method comprising:
(a) applying a potential difference across a pore in contact with a Hel308 helicase and the target polynucleotide;
(b) measuring at least two electrical signals for at least one nucleotide of the target polynucleotide moving through the pore during a full translocation cycle of the Hel308 helicase; and
(c) sequencing the target polynucleotide using the at least two electrical signals measured in (b).

2. The method of claim 1 , wherein (c) comprises sequencing the target polynucleotide by (i) detecting and identifying levels in the at least two electrical signals, and (ii) determining and outputting a sequence of the target polynucleotide based on the detected and identified levels.

3. The method of claim 2 , wherein (i) further comprises outputting one or more parameters selected from full levels, fractional levels, all levels, and level identifiers.

4. The method of claim 3 , wherein (ii) further comprises taking as input the one or more parameters, calling a plurality of bases based on said input, and selecting and outputting the sequence based on confidence information about the called plurality of bases.

5. The method of claim 3 , wherein (ii) further comprises taking as input the one or more parameters, calling a plurality of bases based on said input, and selecting and concatenating with one another portions of a plurality of the called bases based on confidence information about the portions of the called plurality of bases.

6. The method of claim 3 , wherein (ii) further comprises taking as input the one or more parameters, calling a plurality of sequences based on said input, comparing the called sequences to model sequences, and selecting and outputting at least one of the called sequences based on confidence information about the comparison of the called sequence to the model sequence.

7. The method of claim 3 , wherein (ii) further comprises taking as input the one or more parameters, calling a plurality of sequences based on said input, comparing the called sequences to model sequences, and selecting and concatenating with one another portions of a plurality of the called sequences based on confidence information about the comparison of portions of the called plurality of sequences to the model sequence.

8. The method of claim 1 , further comprising repeating steps (a)-(c).

9. The method of claim 1 , wherein the full translocation cycle of the Hel308 helicase comprises nucleotide substrate binding and nucleotide substrate hydrolysis.

10. The method of claim 1 , wherein the pore comprises a constriction zone with a length no longer than five nucleotides.

11. The method of claim 10 , wherein the pore comprises a constriction zone with a length no longer than two nucleotides.

12. The method of claim 1 , wherein the pore comprises a Mycobacterium smegmatis porin A (MspA) pore.

13. The method of claim 1 , wherein the pore comprises a wild type MspA polypeptide comprising one or more mutations selected from the group consisting of D90N, D91N, D93N, D118R, D134R and E139K.

14. The method of claim 1 , wherein the pore comprises an amino acid sequence having at least about 90% homology to SEQ ID NO: 1.

15. The method of claim 1 , wherein the pore comprises an amino acid sequence of SEQ ID NO: 1.

16. The method of claim 1 , wherein the Hel308 helicase comprises a motif having an amino acid sequence selected from the group consisting of SEQ ID NO:04-65.

17. The method of claim 1 , wherein:
the pore is inserted into a membrane having a cis and a trans surface,
the Hel308 helicase contacts the pore on the cis surface of the membrane, and
a solution comprising less than 1 mM ATP or analogue thereof contacts the cis surface of the membrane.

18. The method of claim 17 , wherein the solution comprises less than about 100 μM ATP or analogue thereof.

Assignees

• Illumina Inc

Inventors

• Stava Eric
• Gundlach Jens H
• Mandell Jeffrey G
• Gunderson Kevin L
• Derrington Ian M
• Mohimani Hosein

Classifications

• C12Q1/6869 Primary

  Methods for sequencing · CPC title

• C07K14/35

  from Mycobacteriaceae (F) · CPC title

• G01N27/447

  using electrophoresis · CPC title

• C12Q2521/513

  Winding/unwinding enzyme, e.g. helicase · CPC title

• C12Q2565/631

  being a biochannel or pore · CPC title